Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_assertion type Assertion NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_head.
- NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_assertion description "[The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_provenance.
- NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_assertion evidence source_evidence_literature NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_provenance.
- NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_assertion SIO_000772 25491778 NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_provenance.
- NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_assertion wasDerivedFrom befree-2016 NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_provenance.
- NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_assertion wasGeneratedBy ECO_0000203 NP1246572.RAzAt2x0TWNpa_D-W8Y6iCxuNulU3uM4TlegCuLZpP-nY130_provenance.